![{[setting('site_name')]}](https://projxnews.com/uploads/setting/16983847711140531930.webp)
Nilima Organics Private Limited is poised for substantial growth in India's pharmaceutical landscape with its new 14.55 crore Bulk Drugs & Drug Intermediates Manufacturing Unit Project in Telangana. Located strategically at Gopalpur Village, Yadadri Bhongir District, this Unit-II not only aims to bolster Nilima Organics' production capacity but also contributes significantly to the burgeoning pharmaceutical sector in Telangana.
The key features of the project include a remarkable increase in production capacity to 205 MT/Month of Bulk Drugs, a diverse product portfolio spanning pharmaceuticals, nutraceuticals, and animal health, and the incorporation of cutting-edge technology for quality, efficiency, and environmental compliance. The experienced team leading the project brings extensive expertise in bulk drug manufacturing and quality control.
For Nilima Organics, the benefits encompass increased market reach, improved profitability, and a fortified brand reputation as a trusted supplier of high-quality bulk drugs. The project also brings positive impacts to Telangana, including economic growth through job creation, infrastructure development, and skill enhancement in Yadadri Bhongir District.
As of the current status, construction of the project is expected to commence soon, with completion anticipated by December 2024. Nilima Organics' expansion in Telangana stands as a testament to the company's commitment to excellence and innovation, contributing significantly to the pharmaceutical industry's advancement in the region.
News by Rahul Yelligetti
